Clinical and molecular findings in a Moroccan family with Jervell and Lange-Nielsen syndrome: a case report
© The Author(s). 2017
Received: 5 October 2016
Accepted: 20 February 2017
Published: 2 April 2017
Jervell and Lange-Nielsen syndrome (Online Mendelian Inheritance in Man 220400) is a rare autosomal recessive cardioauditory ion channel disorder that affects 1/200,000 to 1/1,000,000 children. It is characterized by congenital profound bilateral sensorineural hearing loss, a long QT interval, ventricular tachyarrhythmias, and episodes of torsade de pointes on an electrocardiogram. Cardiac symptoms arise mostly in early childhood and consist of syncopal episodes during periods of stress, exercise, or fright and are associated with a high risk of sudden cardiac death. Jervell and Lange-Nielsen syndrome is caused by homozygous or compound heterozygous mutations in KCNQ1 on 11p15.5 or KCNE1 on 1q22.1-q22.2.
We report the case of a 10-year-old Moroccan boy with congenital hearing loss and severely prolonged QT interval who presented with multiple episodes of syncope. His parents are first-degree cousins. We performed Sanger sequencing and identified a homozygous variant in KCNQ1 (c.1343dupC, p.Glu449Argfs*14).
The identification of the genetic substrate in this patient confirmed the clinical diagnosis of Jervell and Lange-Nielsen syndrome and allowed us to provide him with appropriate management and genetic counseling to his family. In addition, this finding contributes to our understanding of genetic disease in the Moroccan population.
KeywordsJervell and Lange-Nielsen syndrome Long QT syndrome Deafness Moroccan Mutation
Jervell and Lange-Nielsen syndrome (JLNS), Mendelian Inheritance in Man (MIM) 220400, is a rare autosomal recessive cardioauditory ion channel disorder that affects 1/200,000 to 1/1,000,000 children [1, 2]. It is characterized by congenital profound bilateral sensorineural hearing loss (SNHL), a long QT interval usually greater than 500 ms, ventricular tachyarrhythmias, and episodes of torsade de pointes on an electrocardiogram (ECG) [2, 3]. Cardiac symptoms mostly arise in early childhood and consist of syncopal episodes during periods of stress, exercise, or fright with a high risk of sudden cardiac death . Homozygous or compound heterozygous loss-of-function mutations in KCNQ1 on 11p15.5 are responsible for 90% of cases of JLNS [4, 5]. Biallelic mutations in KCNE1 on 1q22.1-q22.2 have been identified as an additional cause of JLNS, establishing the genetic heterogeneity of the disease . The two genes encode respectively the α subunits and β subunits of the voltage-gated potassium channel that in the heart conducts the slow delayed rectifying potassium ion (K+) current during cardiomyocyte repolarization, while in the ear it is involved in potassium-rich endolymph production of inner ear hair cells [5, 7]. Here we report the clinical and molecular analysis of a Moroccan family affected by JLNS.
The primary electric disorders, which among others include LQTS, short-QT syndrome (SQTS), Brugada syndrome (BrS), and catecholaminergic polymorphic ventricular tachycardia (CPVT), are often characterized by specific ECG abnormalities either at baseline or during particular conditions, such as exercise (for example, CPVT and LQTS), fever (for example, BrS), or pharmacological challenge (for example, BrS). The list of familial arrhythmia syndromes has been in recent years expanded by the recognition of two other disorders, namely early repolarization syndrome and idiopathic ventricular fibrillation (VF) .
LQTS is a clinically and genetically heterogeneous disorder. Syncopal episodes may occur from infancy through middle age, with risk of sudden death . The autosomal dominant mode of inheritance is typical for all LQTS forms (previously described as the Romano–Ward syndrome). Three genes account for approximately 90% of patients with genotype-positive LQTS. LQT1 is characterized by broad-based T waves and cardiac events during exercise or emotion. It arises from loss-of-function mutations in KCNQ1. In LQT2, T waves are bifid and cardiac events predominantly occur during exercise or emotion. It arises from loss-of-function mutations in KCNH2 (also known as hERG). Gain-of-function mutations in SCN5A are associated to LQT3. These patients show a long ST segment, short T waves, and experience cardiac events predominantly during rest or sleep. Twelve additional genes encoding either ion channel subunits (KCNJ5, KCNE1, KCNE2, and SCN4B) or proteins that regulate ion channel function (AKAP9, CAV3, ANKB, SNT1, CALM1, and CALM2) have been associated with LQTS; however, most of them are only rarely implicated (<1%) .
Jervell and Lange-Nielsen syndrome is a rare clinical variant of LQTS that manifests with extracardiac phenotypes and is inherited in an autosomal recessive fashion. Patients with JLNS present with severe prolongation of the QT interval and congenital SNHL. It is one of the most severe forms of LQTS. By the age of 3 years, 50% of patients have had an event and by the age of 18 years, 90% of patients with JLNS have developed symptoms . Therefore, the real incidence of JLNS is probably underestimated because of its high mortality in early infancy, in particular in populations with a high rate of consanguineous marriages like Morocco . In addition, even in the presence of medical therapy the occurrence of sudden cardiac death in JLNS exceeds 25% .
In this study, we reported the molecular characterization of a KCNQ1 homozygous frameshift mutation c.1343dupC (p.Glu449Argfs*14) in a Moroccan patient with JLNS.
This variant was previously identified in a heterozygous state in a 25-month-old girl of Latino origin with severe bilateral SNHL due to a homozygous mutation of connexin 26. She was repeatedly found to have QTc intervals ≥450 ms in a screening program. Sequencing of 12 LQTS genes identified a de novo heterozygous frameshift mutation described in this report (KCNQ1, c.1343dupC; p.Glu449Argfs*14) . To the best of our knowledge, the case of the Moroccan proband reported here is the first case of JLNS carrying this mutation in a homozygous state.
We report here the clinical and molecular description of a Moroccan patient with JLNS. This diagnosis allowed us to provide an appropriate course of management to the patient and to identify and counsel asymptomatic heterozygous carriers.
We thank the patient and his family.
Availability of data and materials
Available on request.
NA carried out the molecular genetic studies, and drafted the manuscript. NL participated in the clinical diagnosis and helped to draft the manuscript, RB performed clinical examinations and monitoring of the family, IF participated in the clinical diagnosis, RA participated in the clinical diagnosis, MA participated in the sequence alignment, AS participated in the design of the study, CB participated in the design of the study and helped to draft the manuscript, and IR conceived and coordinated the study and helped to draft the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient’s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. A consent for publication was obtained from the family. Statements are available on request.
Ethics approval and consent to participate
Ethics approval and consent to participate was provided by all adults and legal guardians of minor individuals involved in this study. Statements of their signed consent are available on request.
This study was approved by the ethics committee of the National Institute of Health in Rabat, Morocco.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Winbo A, Stattin EL, Diamant UB, Persson J, Jensen SM, Rydberg A. Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden. Europace. 2012;14(12):1799–806.View ArticlePubMedGoogle Scholar
- Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, Berul CI, Bitner-Glindzicz M, Toivonen L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation. 2006;113(6):783–90.View ArticlePubMedGoogle Scholar
- Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54(1):59–68.View ArticlePubMedGoogle Scholar
- Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 1997;15(2):186–9.View ArticlePubMedGoogle Scholar
- Tyson J, Tranebjaerg L, McEntagart M, Larsen LA, Christiansen M, Whiteford ML, Bathen J, Aslaksen B, Sorland SJ, Lund O, et al. Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen. Hum Genet. 2000;107(5):499–503.View ArticlePubMedGoogle Scholar
- Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med. 1997;336(22):1562–7.View ArticlePubMedGoogle Scholar
- Bezzina CR, Lahrouchi N, Priori SG. Genetics of sudden cardiac death. Circ Res. 2015;116(12):1919–36.View ArticlePubMedGoogle Scholar
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.View ArticlePubMedPubMed CentralGoogle Scholar
- Chang RK, Lan YT, Silka MJ, Morrow H, Kwong A, Smith-Lang J, Wallerstein R, Lin HJ. Genetic variants for long QT syndrome among infants and children from a statewide newborn hearing screening program cohort. J Pediatr. 2014;164(3):590–5. e591–3.View ArticlePubMedGoogle Scholar
- Behere SP, Weindling SN. Inherited arrhythmias: The cardiac channelopathies. Ann Pediatr Cardiol. 2015;8(3):210–20.View ArticlePubMedPubMed CentralGoogle Scholar
- Jaouad IC, Elalaoui SC, Sbiti A, Elkerh F, Belmahi L, Sefiani A. Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. J Biosoc Sci. 2009;41(5):575–81.View ArticlePubMedGoogle Scholar